Medicare is coming under scrutiny in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply. The health insurance program said compound drugs were a risk, but ... more 
Medicare is coming under scrutiny in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply. The health insurance program said compound drugs were a risk, but did not use its power to block payment. (Oct. 19) less 
1 / 18
Associated Press Videos
Fri, Oct 19, 2012 6:35 PM EDT